EU Extends Review Of Planned Sanofi-Aventis (France) / Zentiva Deal

January 16, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BRUSSELS, Jan 16 (Reuters) - The European Commission on Friday extended the deadline for its review of plans by French pharmaceuticals producer Sanofi-Aventis (SASY.PA) to buy Czech generic drugmaker Zentiva (ZNTVsp.PR).

Twitter
LinkedIn
Facebook
Email
Print

Alliances Europe

Sanofi (France)